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ABSTRACT 
Atherosclerotic cardiovascular disease (CVD) is a collective term comprising of a group of 
disorders of the heart and blood vessels. These diseases are the largest cause of morbidity and 
premature death worldwide. Coronary heart disease and cerebrovascular disease (stroke) are 
the most frequently occurring diseases. The two major initiators involved in the development 
of atherosclerotic CVD are vascular production of reactive oxygen species (ROS) and lipid 
oxidation. In atherosclerosis development, ROS is associated with rapid loss of anti-
inflammatory and anti-atherogenic activities of the endothelium-derived nitric oxide (NO·) 
resulting in endothelial dysfunction. In part involving activation of the transcription factor 
NF-κB, ROS have been involved in signaling cascades leading to vascular pro-inflammatory 
and pro-thrombotic gene expression. ROS is also a potent activator of matrix 
metalloproteinases (MMPs), which indicate plaque destabilization and rupture. The second 
initiator involved in atherosclerotic CVD is the oxidation of low-density lipoproteins (LDL). 
Oxidation of LDL in vessel wall leads to an inflammatory cascade that activates atherogenic 
pathway leading to foam cell formation. The accumulation of foam cells leads to fatty streak 
formation, which is the earliest visible atherosclerotic lesion. In contrast, the cardiac 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2a) and hepatic apolipoprotein E (apoE) 
expression can improve cardiovascular function. SERCA2a regulates the cardiac contractile 
function by lowering cytoplasmic calcium levels during relaxation, and affecting NO· action 
in vascular cells, while apoE is a critical ligand in the plasma clearance of triglyceride- and 
cholesterol-rich lipoproteins. 
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